Biochemical characterization of three Aspergillus niger β-galactosidases
PDF

Keywords

Food Biotechnology
Microbial Biotechnology

How to Cite

1.
Niu D, Tian X, Mchunu NP, Jia C, Singh S, Liu X, Prior BA, Lu F. Biochemical characterization of three Aspergillus niger β-galactosidases. Electron. J. Biotechnol. [Internet]. 2017 Mar. 16 [cited 2024 Sep. 19];27(1). Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/2017.03.001

Abstract

Background: β-Galactosidases catalyze both hydrolytic and transgalactosylation reactions and therefore deliver many applications in food, medical and biotechnological fields. Aspergillus niger has been a main source of β-galactosidase but the properties are incompletely studied.

Results: Three new β-galactosidases belonging to glycosyl hydrolase family 35 in A. niger strain F0215 were cloned, expressed and biochemically characterized. In addition to the known activity of LacA encoded by lacA, three putative β-galactosidases, designated as LacB, LacC and LacE encoded by the genes lacB, lacC and lacE, respectively, were successfully cloned, sequenced and expressed and secreted by Pichia pastoris. These three proteins as well as LacA have N-terminal signal sequences and are therefore predicted to be extracellular enzymes. They have a typical structure of the fungal β-galactosidases with defined hydrolytic and transgalactosylation activities on lactose. However, their activity properties differed. In particular, LacB and lacE displayed maximum hydrolytic activity at pH 4~5 and 50ºC, while LacC exhibited maximum activity at pH 3.5 and 60ºC. All β-galactosidases carried out transgalactosylation activity optimally in an acidic environment.

Conclusions: Three new β-galactosidases belonging to glycosyl hydrolase family 35 in A. niger strain F0215 were cloned, and biochemically characterized. In addition to the known LacA, A. niger has at least 3 family members of β-galactosidases with remarkably different biochemical properties.

PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.